logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Oncogenomics Handbook William J Larochelle Richard A Shimkets

  • SKU: BELL-4112120
Oncogenomics Handbook William J Larochelle Richard A Shimkets
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Oncogenomics Handbook William J Larochelle Richard A Shimkets instant download after payment.

Publisher: Humana Press
File Extension: PDF
File size: 13.54 MB
Pages: 769
Author: William J Larochelle; Richard A Shimkets
ISBN: 9781588294258, 9781592598939, 1588294250, 1592598935
Language: English
Year: 2005

Product desciption

Oncogenomics Handbook William J Larochelle Richard A Shimkets by William J Larochelle; Richard A Shimkets 9781588294258, 9781592598939, 1588294250, 1592598935 instant download after payment.

An integrated overview of cancer drug discovery and development from the bench to the clinic, showing with broad strokes and representative examples the drug development process as a network of linked components leading from the discovered target to the ultimate therapeutic product. Following a systems biology approach, the authors explain genomic databases and how to discover oncological targets from them, how then to advance from the gene and transcript to the level of protein biochemistry, how next to move from the chemical realm to that of the living cell and, ultimately, pursue animal modeling and clinical development. Emerging cancer therapeutics including Ritux an, Erbitux, Gleevec Herceptin, Avastin, ABX-EGF, Velcade, Kepivance, Iressa, Tarceva, and Zevalin are addressed. Highlights include cancer genomics, pharmacogenomics, transcriptomics, gene expression analysis, proteomic and enzymatic cancer profiling technologies, and cellular and animal approaches to cancer target validation.

Related Products